Skip to content

Machine learning combined with fMRI identifies dynamic brain network alterations in post-stroke depression: A dual-center cross-sectional study.

Aug 2026 · Journal of Affective Disorders · pp. 122395 · 0 citations · 35 references
Medicine

Abstract

Objective

Post-stroke depression (PSD) is under-recognized and associated with poorer rehabilitation outcomes and quality of life. We characterized PSD-related alterations in large-scale brain network dynamics and evaluated their cross-center classification performance.

Methods

This dual-center cross-sectional study included 300 patients with post-stroke motor impairment: 100 with and 100 without PSD in the development cohort, and 50 per group in the external validation cohort. Resting-state functional MRI, sliding-window dynamic functional connectivity, and clustering across K = 2-8 state resolutions were combined with nested cross-validation, nine machine-learning classifiers, and SHAP interpretation. Sensitivity analysis excluded users of antidepressants, anxiolytics, or sedative-hypnotics.

Results

The five-state solution provided the best balance of discrimination and interpretability. The support vector machine achieved internally cross-validated and external validation AUCs of 0.838 and 0.784, respectively. Higher proportion and longer dwell time of a globally integrated state, lower proportion and dwell time of a stable modular state, and higher self-transition probability of a low-integration state shifted classification toward PSD. After medication users were excluded, the artificial neural network under the five-state solution achieved internally cross-validated and external validation AUCs of 0.798 and 0.793, respectively; a higher proportion of the globally integrated state also remained among the most informative features.

Conclusions

PSD was associated with altered temporal organization and reduced stability of large-scale functional networks. Dynamic state features may serve as interpretable candidate imaging markers for PSD classification, but longitudinal multicenter validation is required before clinical application.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.